GENETIC CHOLESTERYL ESTER TRANSFER PROTEIN-DEFICIENCY CAUSED BY 2 PREVALENT MUTATIONS AS A MAJOR DETERMINANT OF INCREASED LEVELS OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL

被引:221
作者
INAZU, A
JIANG, XC
HARAKI, T
YAGI, K
KAMON, N
KOIZUMI, J
MABUCHI, H
TAKEDA, R
TAKATA, K
MORIYAMA, Y
DOI, M
TALL, A
机构
[1] COLUMBIA UNIV, COLL PHYS & SURG, DEPT MED, DIV MOLEC MED, NEW YORK, NY 10032 USA
[2] HIROSHIMA RAILWAY HOSP, DEPT INTERNAL MED, HIROSHIMA 732, JAPAN
[3] KOCHI PREFECTURAL TOSA YAMADA HLTH CTR, KOCHI 782, JAPAN
关键词
CHOLESTERYL ESTER TRANSFER PROTEIN DEFICIENCY; HIGH DENSITY LIPOPROTEIN; HYPER-ALPHALIPOPROTEINEMIA; MISSENSE MUTATION; SPLICE DONOR SITE MUTATION;
D O I
10.1172/JCI117537
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Genetic determinants of HDL cholesterol (HDL-C) levels in the general population are poorly understood. We previously described plasma cholesteryl ester transfer protein (CETP) deficiency due to an intron 14 G(+1)-to-A mutation(Int14 A) in several families with very high HDL-C levels in Japan. Subjects with HDL-C greater than or equal to 100 mg/dl (n = 130) were screened by PCR single strand conformational polymorphism analysis of the CETP gene. Two other mutations were identified by DNA sequencing or primer-mediated restriction map modification of PCR products: a novel intron 14 splice donor site mutation caused by a T insertion at position +3 from the exon14/intron14 boundary (Int14 T) and a missense mutation (Asp(442) to Gly) within exon 15 (D442G). The Int14 T mutation was only found in one family. However, the D442G and Int14 A mutations were highly prevalent in subjects with HDL-C greater than or equal to 60 mg/dl, with combined allele frequencies of 9%, 12%, 21%, and 43% for HDL-C 60-79, 80-99, 100-119, and greater than or equal to 120 mg/dl, respectively. Furthermore, prevalences of the D442G and Int14 A mutations were extremely high in a general sample of Japanese men (n = 236), with heterozygote frequencies of 7% and 2%, respectively. These two mutations accounted for about 10% of the total variance of HDL-C in this population. The phenotype in a genetic compound heterozygote (Int14 T and Int14 A) was similar to that of Int14 A homozygotes (no detectable CETP and markedly increased HDL-C), indicating that the Int14 T produces a null allele. In four D442G homozygotes, mean HDL-C levels (86+/-26 mg/dl) were lower than in Int14 A homozygotes (158+/-35 mg/dl), reflecting residual CETP activity in plasma. In 47 D442G heterozygotes, mean HDL-C levels were 91+/-23 mg/dl, similar to the level in D442G homozygotes, and significantly greater than mean HDL-C levels in Int14 A heterozygotes (69+/-15 mg/dl). Thus, the D442G mutation acts differently to the null mutations with weaker effects on HDL in the homozygous state and stronger effects in the heterozygotes, suggesting dominant expression of a partially defective allele. CETP deficiency, reflecting two prevalent mutations (D442G and Int14 A), is the first example of a genetic deficiency state which is sufficiently common to explain a significant fraction of the variation in HDL-C in the general population.
引用
收藏
页码:1872 / 1882
页数:11
相关论文
共 51 条
[11]  
COOPER DN, 1993, HUMAN GENE MUTATION, P239
[12]  
Dawson-Saunders B, 1990, BASIC CLIN BIOSTATIS, P124
[13]   CLONING AND SEQUENCING OF HUMAN CHOLESTERYL ESTER TRANSFER PROTEIN CDNA [J].
DRAYNA, D ;
JARNAGIN, AS ;
MCLEAN, J ;
HENZEL, W ;
KOHR, W ;
FIELDING, C ;
LAWN, R .
NATURE, 1987, 327 (6123) :632-634
[14]  
FLEISHER LN, 1982, J BIOL CHEM, V257, P6653
[15]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[16]   TOTAL AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN THE SERUM AND RISK OF MORTALITY - EVIDENCE OF A THRESHOLD EFFECT [J].
GOLDBOURT, U ;
HOLTZMAN, E ;
NEUFELD, HN .
BMJ-BRITISH MEDICAL JOURNAL, 1985, 290 (6477) :1239-1243
[17]  
GORDON DJ, 1989, NEW ENGL J MED, V321, P1311
[18]   CHOLESTERYL ESTER TRANSFER PROTEIN-DEFICIENCY CAUSED BY A NONSENSE MUTATION DETECTED IN THE PATIENTS MACROPHAGE MESSENGER-RNA [J].
GOTODA, T ;
KINOSHITA, M ;
SHIMANO, H ;
HARADA, K ;
SHIMADA, M ;
OHSUGA, J ;
TERAMOTO, T ;
YAZAKI, Y ;
YAMADA, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (01) :519-524
[19]  
GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015
[20]   HEPATIC LIPASE DEFICIENCY - CLINICAL, BIOCHEMICAL, AND MOLECULAR-GENETIC CHARACTERISTICS [J].
HEGELE, RA ;
LITTLE, JA ;
VEZINA, C ;
MAGUIRE, GF ;
TU, LL ;
WOLEVER, TS ;
JENKINS, DJA ;
CONNELLY, PW .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (05) :720-728